FasL+PD‐L2+ Identifies a Novel Immunosuppressive Neutrophil Population in Human Gastric Cancer That Promotes Disease Progression

Abstract Neutrophils constitute abundant cellular components in human gastric cancer (GC) tissues, but their protumorigenic subset in pathogenesis of GC progression is unclear. Here, it is found that patients with GC show significantly higher neutrophil infiltration in tumors that is regulated by CX...

Full description

Bibliographic Details
Main Authors: Zhi‐Guo Shan, Yong‐Liang Zhao, Jin‐Yu Zhang, Zong‐Bao Yan, Ting‐Ting Wang, Fang‐Yuan Mao, Yong‐Sheng Teng, Liu‐Sheng Peng, Wan‐Yan Chen, Pan Wang, Ping Cheng, Wen‐Qing Tian, Jun Chen, Weisan Chen, Yuan Zhuang
Format: Article
Language:English
Published: Wiley 2022-02-01
Series:Advanced Science
Subjects:
Online Access:https://doi.org/10.1002/advs.202103543
_version_ 1819278403358949376
author Zhi‐Guo Shan
Yong‐Liang Zhao
Jin‐Yu Zhang
Zong‐Bao Yan
Ting‐Ting Wang
Fang‐Yuan Mao
Yong‐Sheng Teng
Liu‐Sheng Peng
Wan‐Yan Chen
Pan Wang
Ping Cheng
Wen‐Qing Tian
Jun Chen
Weisan Chen
Yuan Zhuang
author_facet Zhi‐Guo Shan
Yong‐Liang Zhao
Jin‐Yu Zhang
Zong‐Bao Yan
Ting‐Ting Wang
Fang‐Yuan Mao
Yong‐Sheng Teng
Liu‐Sheng Peng
Wan‐Yan Chen
Pan Wang
Ping Cheng
Wen‐Qing Tian
Jun Chen
Weisan Chen
Yuan Zhuang
author_sort Zhi‐Guo Shan
collection DOAJ
description Abstract Neutrophils constitute abundant cellular components in human gastric cancer (GC) tissues, but their protumorigenic subset in pathogenesis of GC progression is unclear. Here, it is found that patients with GC show significantly higher neutrophil infiltration in tumors that is regulated by CXCL12‐CXCR4 chemotaxis. These tumor‐infiltrating neutrophils express high level immunosuppressive molecules FasL and PD‐L2, and this FasL+PD‐L2+ neutrophil subset with a unique phenotype constitutes at least 20% of all neutrophils in advanced GC and predicts poor patient survival. Tumor induces neutrophils to express FasL and PD‐L2 proteins with similar phenotype to those in GC tumors in both time‐dependent and dose‐dependent manners. Mechanistically, Th17 cell‐derived IL‐17A and tumor cell‐derived G‐CSF can significantly induce neutrophil FasL and PD‐L2 expression via activating ERK‐NF‐κB and JAK‐STAT3 signaling pathway, respectively. Importantly, upon over‐expressing FasL and PD‐L2, neutrophils acquire immunosuppressive functions on tumor‐specific CD8+ T‐cells and promote the growth and progression of human GC tumors in vitro and in vivo, which can be reversed by blocking FasL and PD‐L2 on these neutrophils. Thus, the work identifies a novel protumorigenic FasL+PD‐L2+ neutrophil subset in GC and provides new insights for human cancer immunosuppression and anti‐cancer therapies targeting these pathogenic cells.
first_indexed 2024-12-24T00:11:27Z
format Article
id doaj.art-61422758079c4ea3a1bc9e4a6a6ffd29
institution Directory Open Access Journal
issn 2198-3844
language English
last_indexed 2024-12-24T00:11:27Z
publishDate 2022-02-01
publisher Wiley
record_format Article
series Advanced Science
spelling doaj.art-61422758079c4ea3a1bc9e4a6a6ffd292022-12-21T17:24:52ZengWileyAdvanced Science2198-38442022-02-0195n/an/a10.1002/advs.202103543FasL+PD‐L2+ Identifies a Novel Immunosuppressive Neutrophil Population in Human Gastric Cancer That Promotes Disease ProgressionZhi‐Guo Shan0Yong‐Liang Zhao1Jin‐Yu Zhang2Zong‐Bao Yan3Ting‐Ting Wang4Fang‐Yuan Mao5Yong‐Sheng Teng6Liu‐Sheng Peng7Wan‐Yan Chen8Pan Wang9Ping Cheng10Wen‐Qing Tian11Jun Chen12Weisan Chen13Yuan Zhuang14Department of General Surgery and Center of Minimal Invasive Gastrointestinal Surgery Southwest Hospital Third Military Medical University Chongqing 400038 ChinaDepartment of General Surgery and Center of Minimal Invasive Gastrointestinal Surgery Southwest Hospital Third Military Medical University Chongqing 400038 ChinaNational Engineering Research Center of Immunological Products Department of Microbiology and Biochemical Pharmacy College of Pharmacy and Laboratory Medicine Third Military Medical University Chongqing 400038 ChinaDepartment of General Surgery and Center of Minimal Invasive Gastrointestinal Surgery Southwest Hospital Third Military Medical University Chongqing 400038 ChinaChongqing Key Research Laboratory for Drug Metabolism Department of Pharmacology Chongqing Medical University Chongqing 400016 ChinaNational Engineering Research Center of Immunological Products Department of Microbiology and Biochemical Pharmacy College of Pharmacy and Laboratory Medicine Third Military Medical University Chongqing 400038 ChinaNational Engineering Research Center of Immunological Products Department of Microbiology and Biochemical Pharmacy College of Pharmacy and Laboratory Medicine Third Military Medical University Chongqing 400038 ChinaNational Engineering Research Center of Immunological Products Department of Microbiology and Biochemical Pharmacy College of Pharmacy and Laboratory Medicine Third Military Medical University Chongqing 400038 ChinaNational Engineering Research Center of Immunological Products Department of Microbiology and Biochemical Pharmacy College of Pharmacy and Laboratory Medicine Third Military Medical University Chongqing 400038 ChinaNational Engineering Research Center of Immunological Products Department of Microbiology and Biochemical Pharmacy College of Pharmacy and Laboratory Medicine Third Military Medical University Chongqing 400038 ChinaNational Engineering Research Center of Immunological Products Department of Microbiology and Biochemical Pharmacy College of Pharmacy and Laboratory Medicine Third Military Medical University Chongqing 400038 ChinaDepartment of Endocrinology the First Affiliated Hospital of Chongqing Medical University Chongqing 400016 ChinaDepartment of General Surgery and Center of Minimal Invasive Gastrointestinal Surgery Southwest Hospital Third Military Medical University Chongqing 400038 ChinaLa Trobe Institute of Molecular Science La Trobe University Bundoora Victoria 3085 AustraliaDepartment of Gastroenterology the Affiliated Hospital of Southwest Medical University Luzhou Sichuan 646000 ChinaAbstract Neutrophils constitute abundant cellular components in human gastric cancer (GC) tissues, but their protumorigenic subset in pathogenesis of GC progression is unclear. Here, it is found that patients with GC show significantly higher neutrophil infiltration in tumors that is regulated by CXCL12‐CXCR4 chemotaxis. These tumor‐infiltrating neutrophils express high level immunosuppressive molecules FasL and PD‐L2, and this FasL+PD‐L2+ neutrophil subset with a unique phenotype constitutes at least 20% of all neutrophils in advanced GC and predicts poor patient survival. Tumor induces neutrophils to express FasL and PD‐L2 proteins with similar phenotype to those in GC tumors in both time‐dependent and dose‐dependent manners. Mechanistically, Th17 cell‐derived IL‐17A and tumor cell‐derived G‐CSF can significantly induce neutrophil FasL and PD‐L2 expression via activating ERK‐NF‐κB and JAK‐STAT3 signaling pathway, respectively. Importantly, upon over‐expressing FasL and PD‐L2, neutrophils acquire immunosuppressive functions on tumor‐specific CD8+ T‐cells and promote the growth and progression of human GC tumors in vitro and in vivo, which can be reversed by blocking FasL and PD‐L2 on these neutrophils. Thus, the work identifies a novel protumorigenic FasL+PD‐L2+ neutrophil subset in GC and provides new insights for human cancer immunosuppression and anti‐cancer therapies targeting these pathogenic cells.https://doi.org/10.1002/advs.202103543FasLgastric cancerneutrophilsPD‐L2
spellingShingle Zhi‐Guo Shan
Yong‐Liang Zhao
Jin‐Yu Zhang
Zong‐Bao Yan
Ting‐Ting Wang
Fang‐Yuan Mao
Yong‐Sheng Teng
Liu‐Sheng Peng
Wan‐Yan Chen
Pan Wang
Ping Cheng
Wen‐Qing Tian
Jun Chen
Weisan Chen
Yuan Zhuang
FasL+PD‐L2+ Identifies a Novel Immunosuppressive Neutrophil Population in Human Gastric Cancer That Promotes Disease Progression
Advanced Science
FasL
gastric cancer
neutrophils
PD‐L2
title FasL+PD‐L2+ Identifies a Novel Immunosuppressive Neutrophil Population in Human Gastric Cancer That Promotes Disease Progression
title_full FasL+PD‐L2+ Identifies a Novel Immunosuppressive Neutrophil Population in Human Gastric Cancer That Promotes Disease Progression
title_fullStr FasL+PD‐L2+ Identifies a Novel Immunosuppressive Neutrophil Population in Human Gastric Cancer That Promotes Disease Progression
title_full_unstemmed FasL+PD‐L2+ Identifies a Novel Immunosuppressive Neutrophil Population in Human Gastric Cancer That Promotes Disease Progression
title_short FasL+PD‐L2+ Identifies a Novel Immunosuppressive Neutrophil Population in Human Gastric Cancer That Promotes Disease Progression
title_sort fasl pd l2 identifies a novel immunosuppressive neutrophil population in human gastric cancer that promotes disease progression
topic FasL
gastric cancer
neutrophils
PD‐L2
url https://doi.org/10.1002/advs.202103543
work_keys_str_mv AT zhiguoshan faslpdl2identifiesanovelimmunosuppressiveneutrophilpopulationinhumangastriccancerthatpromotesdiseaseprogression
AT yongliangzhao faslpdl2identifiesanovelimmunosuppressiveneutrophilpopulationinhumangastriccancerthatpromotesdiseaseprogression
AT jinyuzhang faslpdl2identifiesanovelimmunosuppressiveneutrophilpopulationinhumangastriccancerthatpromotesdiseaseprogression
AT zongbaoyan faslpdl2identifiesanovelimmunosuppressiveneutrophilpopulationinhumangastriccancerthatpromotesdiseaseprogression
AT tingtingwang faslpdl2identifiesanovelimmunosuppressiveneutrophilpopulationinhumangastriccancerthatpromotesdiseaseprogression
AT fangyuanmao faslpdl2identifiesanovelimmunosuppressiveneutrophilpopulationinhumangastriccancerthatpromotesdiseaseprogression
AT yongshengteng faslpdl2identifiesanovelimmunosuppressiveneutrophilpopulationinhumangastriccancerthatpromotesdiseaseprogression
AT liushengpeng faslpdl2identifiesanovelimmunosuppressiveneutrophilpopulationinhumangastriccancerthatpromotesdiseaseprogression
AT wanyanchen faslpdl2identifiesanovelimmunosuppressiveneutrophilpopulationinhumangastriccancerthatpromotesdiseaseprogression
AT panwang faslpdl2identifiesanovelimmunosuppressiveneutrophilpopulationinhumangastriccancerthatpromotesdiseaseprogression
AT pingcheng faslpdl2identifiesanovelimmunosuppressiveneutrophilpopulationinhumangastriccancerthatpromotesdiseaseprogression
AT wenqingtian faslpdl2identifiesanovelimmunosuppressiveneutrophilpopulationinhumangastriccancerthatpromotesdiseaseprogression
AT junchen faslpdl2identifiesanovelimmunosuppressiveneutrophilpopulationinhumangastriccancerthatpromotesdiseaseprogression
AT weisanchen faslpdl2identifiesanovelimmunosuppressiveneutrophilpopulationinhumangastriccancerthatpromotesdiseaseprogression
AT yuanzhuang faslpdl2identifiesanovelimmunosuppressiveneutrophilpopulationinhumangastriccancerthatpromotesdiseaseprogression